ReP USP - Resultado da busca

Artigo de periodico
Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/ Cas9 constructs (2024)
Mori, Augusto Akira ; Malaquias, Vanessa Barbosa ; Bonjour, Kennedy ; Ferreira, Glaucio Monteiro ; Bortolin, Raul Hernandes ; Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Gonçalves, Rodrigo Marques; Faludi, Andre Arpad; Bastos, Gisele Monteiro; Thurow, Helena; Sampaio, Marcelo Ferraz; Ciconelli, Rozana Mesquita; Cury, Adriano Namo; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Gene. Unidades: FCF, ICB
Subjects: HIPERCOLESTEROLEMIA, RECEPTORES DE LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Augusto Akira et al. Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/ Cas9 constructs. Gene, v. 890, p. 1-12 art. 147821, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.gene.2023.147821. Acesso em: 18 nov. 2024.
APA
Mori, A. A., Malaquias, V. B., Bonjour, K., Ferreira, G. M., Bortolin, R. H., Borges, J. B., et al. (2024). Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/ Cas9 constructs. Gene, 890, 1-12 art. 147821. doi:10.1016/j.gene.2023.147821
NLM
Mori AA, Malaquias VB, Bonjour K, Ferreira GM, Bortolin RH, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Thurow H, Sampaio MF, Ciconelli RM, Cury AN, Fajardo CM, Hirata RDC, Hirata MH. Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/ Cas9 constructs [Internet]. Gene. 2024 ; 890 1-12 art. 147821.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.gene.2023.147821
Vancouver
Mori AA, Malaquias VB, Bonjour K, Ferreira GM, Bortolin RH, Borges JB, Oliveira VF de, Gonçalves RM, Faludi AA, Bastos GM, Thurow H, Sampaio MF, Ciconelli RM, Cury AN, Fajardo CM, Hirata RDC, Hirata MH. Effects of LDLR variants rs5928, rs750518671 and rs879254797 on protein structure and functional activity in HepG2 cells transfected with CRISPR/ Cas9 constructs [Internet]. Gene. 2024 ; 890 1-12 art. 147821.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.gene.2023.147821
Artigo de periodico
The impact of miR-155-5p on myotube differentiation: elucidating molecular targets in skeletal muscle disorders (2024)
Lopes, Letícia Oliveira; Cury, Sarah Santiloni ; Moraes, Diogo de ; Oliveira, Jakeline Santos; Oliveira, Grasieli de; Marques, Otavio Cabral ; Fernandez, Geysson Javier ; Hirata, Mario Hiroyuki ; Wang, Da Zhi ; Dal-Pai-Silva, Maeli ; Carvalho, Robson Francisco ; Freire, Paula Paccielli
Source: International Journal of Molecular Sciences. Unidades: FM, FCF, ICB
Subjects: MICRORNAS, DISTROFIA MUSCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Letícia Oliveira et al. The impact of miR-155-5p on myotube differentiation: elucidating molecular targets in skeletal muscle disorders. International Journal of Molecular Sciences, v. 25, p. 1-18, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms25031777. Acesso em: 18 nov. 2024.
APA
Lopes, L. O., Cury, S. S., Moraes, D. de, Oliveira, J. S., Oliveira, G. de, Marques, O. C., et al. (2024). The impact of miR-155-5p on myotube differentiation: elucidating molecular targets in skeletal muscle disorders. International Journal of Molecular Sciences, 25, 1-18. doi:10.3390/ijms25031777
NLM
Lopes LO, Cury SS, Moraes D de, Oliveira JS, Oliveira G de, Marques OC, Fernandez GJ, Hirata MH, Wang DZ, Dal-Pai-Silva M, Carvalho RF, Freire PP. The impact of miR-155-5p on myotube differentiation: elucidating molecular targets in skeletal muscle disorders [Internet]. International Journal of Molecular Sciences. 2024 ; 25 1-18.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.3390/ijms25031777
Vancouver
Lopes LO, Cury SS, Moraes D de, Oliveira JS, Oliveira G de, Marques OC, Fernandez GJ, Hirata MH, Wang DZ, Dal-Pai-Silva M, Carvalho RF, Freire PP. The impact of miR-155-5p on myotube differentiation: elucidating molecular targets in skeletal muscle disorders [Internet]. International Journal of Molecular Sciences. 2024 ; 25 1-18.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.3390/ijms25031777
Artigo de periodico
T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections (2023)
Santiago-Carvalho, Igor ; Almeida-Santos, Gislane ; Macêdo, Bruna de Gois ; Barbosa-Bomfim, Caio César ; Almeida, Fabricio Moreira ; Cione, Marcos Vinícios Pinheiro ; Vardam-Kaur, Trupti ; Masuda, Mia ; Dijk, Sarah Van ; Melo, Bruno Marcel Silva de ; Nascimento, Rogério Silva do; Souza, Rebeka da Conceição ; Peixoto-Rangel, Alba Lucínia ; Coutinho-Silva, Robson ; Lassounskaia, Elena ; Silva, Henrique Borges da ; Hirata, Mario Hiroyuki ; Alves Filho, José Carlos ; Alvarez, José Maria ; Lima, Maria Regina D'Império
Source: Cell Reports. Unidades: FCF, FMRP, ICB
Subjects: IMUNOLOGIA, PNEUMOPATIAS, TUBERCULOSE PULMONAR, INFLUENZA, MODELOS ANIMAIS DE DOENÇAS, RATOS, QUIMIOCINAS, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTIAGO-CARVALHO, Igor et al. T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections. Cell Reports, v. 42, n. 11, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2023.113448. Acesso em: 18 nov. 2024.
APA
Santiago-Carvalho, I., Almeida-Santos, G., Macêdo, B. de G., Barbosa-Bomfim, C. C., Almeida, F. M., Cione, M. V. P., et al. (2023). T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections. Cell Reports, 42( 11). doi:10.1016/j.celrep.2023.113448
NLM
Santiago-Carvalho I, Almeida-Santos G, Macêdo B de G, Barbosa-Bomfim CC, Almeida FM, Cione MVP, Vardam-Kaur T, Masuda M, Dijk SV, Melo BMS de, Nascimento RS do, Souza R da C, Peixoto-Rangel AL, Coutinho-Silva R, Lassounskaia E, Silva HB da, Hirata MH, Alves Filho JC, Alvarez JM, Lima MRD'I. T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections [Internet]. Cell Reports. 2023 ; 42( 11):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.celrep.2023.113448
Vancouver
Santiago-Carvalho I, Almeida-Santos G, Macêdo B de G, Barbosa-Bomfim CC, Almeida FM, Cione MVP, Vardam-Kaur T, Masuda M, Dijk SV, Melo BMS de, Nascimento RS do, Souza R da C, Peixoto-Rangel AL, Coutinho-Silva R, Lassounskaia E, Silva HB da, Hirata MH, Alves Filho JC, Alvarez JM, Lima MRD'I. T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections [Internet]. Cell Reports. 2023 ; 42( 11):[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.celrep.2023.113448
Artigo de periodico
Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII (2023)
Greco, Gabriel Luis Cardoso; Segretti, Natanael; Zapatero, Celerino Abad ; Movahedzadehc, Farahnaz; Hirata, Mario Hiroyuki ; Ferreira, Elizabeth Igne ; Ferreira, Glaucio Monteiro
Source: Journal of Biomolecular Structure and Dynamics. Unidade: FCF
Subjects: TUBERCULOSE, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GRECO, Gabriel Luis Cardoso et al. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics, 2023Tradução . . Disponível em: https://dx.doi.org/10.1080/07391102.2023.2270528. Acesso em: 18 nov. 2024.
APA
Greco, G. L. C., Segretti, N., Zapatero, C. A., Movahedzadehc, F., Hirata, M. H., Ferreira, E. I., & Ferreira, G. M. (2023). Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII. Journal of Biomolecular Structure and Dynamics. doi:10.1080/07391102.2023.2270528
NLM
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Vancouver
Greco GLC, Segretti N, Zapatero CA, Movahedzadehc F, Hirata MH, Ferreira EI, Ferreira GM. Exploring the dark side of tertiary and quaternary structure dynamics in MtbFBPaseII [Internet]. Journal of Biomolecular Structure and Dynamics. 2023 ;[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1080/07391102.2023.2270528
Artigo de periodico
Post-Partum depression lactating rat model for evaluating ketamine's safety as a Pharmacotherapeutic treatment: roles in cardiac and urinary function (2022)
Fukushima, André Rinaldi ; Suarez, Pedro Enrique Navas; Muñoz, Juliana Weckx Peña; Ricci, Esther Lopes ; Leoni, Luis Antonio Baffile; Caperuto, Érico Chagas ; Yanase, Leandro; Santana, Jeferson; França, Elias de ; Delorenzi, Jan Carlo Morais O. Bertassoni ; Terrivel, Alcides Felix; Ferreira, Glaucio Monteiro ; Hirata, Mario Hiroyuki ; Waziry, Paula A. Faria ; Nicoletti, Maria Aparecida ; Spinosa, Helenice de Souza
Source: Journal of Cardiovascular Development and Disease. Unidades: FMVZ, FCF
Subjects: DEPRESSÃO PÓS-PARTO, CISTITE, MODELOS ANIMAIS, NEUROHORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUKUSHIMA, André Rinaldi et al. Post-Partum depression lactating rat model for evaluating ketamine's safety as a Pharmacotherapeutic treatment: roles in cardiac and urinary function. Journal of Cardiovascular Development and Disease, v. 9, p. 1-17 art. 299, 2022Tradução . . Disponível em: https://doi.org/10.3390/jcdd9090299. Acesso em: 18 nov. 2024.
APA
Fukushima, A. R., Suarez, P. E. N., Muñoz, J. W. P., Ricci, E. L., Leoni, L. A. B., Caperuto, É. C., et al. (2022). Post-Partum depression lactating rat model for evaluating ketamine's safety as a Pharmacotherapeutic treatment: roles in cardiac and urinary function. Journal of Cardiovascular Development and Disease, 9, 1-17 art. 299. doi:10.3390/jcdd9090299
NLM
Fukushima AR, Suarez PEN, Muñoz JWP, Ricci EL, Leoni LAB, Caperuto ÉC, Yanase L, Santana J, França E de, Delorenzi JCMOB, Terrivel AF, Ferreira GM, Hirata MH, Waziry PAF, Nicoletti MA, Spinosa H de S. Post-Partum depression lactating rat model for evaluating ketamine's safety as a Pharmacotherapeutic treatment: roles in cardiac and urinary function [Internet]. Journal of Cardiovascular Development and Disease. 2022 ; 9 1-17 art. 299.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/jcdd9090299
Vancouver
Fukushima AR, Suarez PEN, Muñoz JWP, Ricci EL, Leoni LAB, Caperuto ÉC, Yanase L, Santana J, França E de, Delorenzi JCMOB, Terrivel AF, Ferreira GM, Hirata MH, Waziry PAF, Nicoletti MA, Spinosa H de S. Post-Partum depression lactating rat model for evaluating ketamine's safety as a Pharmacotherapeutic treatment: roles in cardiac and urinary function [Internet]. Journal of Cardiovascular Development and Disease. 2022 ; 9 1-17 art. 299.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/jcdd9090299
Artigo de periodico
Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases (2021)
Freitas, Renata Caroline Costa de ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Aikawa, Elena
Source: Biomolecules. Unidade: FCF
Subjects: BIOMARCADORES, PROTEÍNAS, LIPÍDEOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, v. 11, p. 1-21 art. 388, 2021Tradução . . Disponível em: https://doi.org/10.3390/biom11030388. Acesso em: 18 nov. 2024.
APA
Freitas, R. C. C. de, Hirata, R. D. C., Hirata, M. H., & Aikawa, E. (2021). Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases. Biomolecules, 11, 1-21 art. 388. doi:10.3390/biom11030388
NLM
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/biom11030388
Vancouver
Freitas RCC de, Hirata RDC, Hirata MH, Aikawa E. Circulating extracellular vesicles as biomarkers and drug delivery vehicles in cardiovascular diseases [Internet]. Biomolecules. 2021 ; 11 1-21 art. 388.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/biom11030388
Artigo de periodico
P2x7 receptor signaling blockade reduces lung inflammation and necrosis during severe experimental tuberculosis (2021)
Carvalho, Igor Santiago ; Santos, Gislane Almeida ; Bomfim, Caio César Barbosa ; Souza, Paula Carolina de; Silva, Juan Carlo Santos e ; Melo, Bruno Marcel Silva de ; Amaral, Eduardo Pinheiro ; Cione, Marcos Vinícios Pinheiro; Lasunskaia, Elena ; Hirata, Mario Hiroyuki ; Alves Filho, José Carlos Farias ; Nakaya, Helder Takashi Imoto ; Alvarez, José Maria ; Lima, Maria Regina D'Império
Source: Frontiers in Cellular and Infection Microbiology. Unidades: FCF, FMRP, ICB
Subjects: TUBERCULOSE PULMONAR, RECEPTORES, PULMÃO, EXPRESSÃO GÊNICA, NECROSE, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, CAMUNDONGOS, CÉLULAS DENDRÍTICAS, CÉLULAS MIELOIDES, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Igor Santiago et al. P2x7 receptor signaling blockade reduces lung inflammation and necrosis during severe experimental tuberculosis. Frontiers in Cellular and Infection Microbiology, v. 11, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2021.672472. Acesso em: 18 nov. 2024.
APA
Carvalho, I. S., Santos, G. A., Bomfim, C. C. B., Souza, P. C. de, Silva, J. C. S. e, Melo, B. M. S. de, et al. (2021). P2x7 receptor signaling blockade reduces lung inflammation and necrosis during severe experimental tuberculosis. Frontiers in Cellular and Infection Microbiology, 11, 1-11. doi:10.3389/fcimb.2021.672472
NLM
Carvalho IS, Santos GA, Bomfim CCB, Souza PC de, Silva JCS e, Melo BMS de, Amaral EP, Cione MVP, Lasunskaia E, Hirata MH, Alves Filho JCF, Nakaya HTI, Alvarez JM, Lima MRD'I. P2x7 receptor signaling blockade reduces lung inflammation and necrosis during severe experimental tuberculosis [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fcimb.2021.672472
Vancouver
Carvalho IS, Santos GA, Bomfim CCB, Souza PC de, Silva JCS e, Melo BMS de, Amaral EP, Cione MVP, Lasunskaia E, Hirata MH, Alves Filho JCF, Nakaya HTI, Alvarez JM, Lima MRD'I. P2x7 receptor signaling blockade reduces lung inflammation and necrosis during severe experimental tuberculosis [Internet]. Frontiers in Cellular and Infection Microbiology. 2021 ; 11 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fcimb.2021.672472
Artigo de periodico
Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria (2021)
Bomfim, Caio César Barbosa ; Amaral, Eduardo Pinheiro ; Carvalho, Igor Santiago ; Santos, Gislane Almeida ; Salles, Érika Machado de ; Hastreiter, Araceli Aparecida ; Nascimento, Rogério Silva do; Almeida, Fabricio M.; Simão, Thatiana Lopes Biá Ventura ; Rezende, Andreza Linhares; Hirata, Mario Hiroyuki ; Fock, Ricardo Ambrósio ; Alvarez, José Maria ; Lasunskaia, Elena B ; Lima, Maria Regina D'Império
Source: Journal of Infectious Diseases. Unidades: ICB, FCF
Subjects: TUBERCULOSE PULMONAR, CÉLULAS SANGUINEAS, GRANULOCITOS CITOPLASMATICOS, MEDULA ÓSSEA DE ANIMAL, VIRULÊNCIA, NEUTRÓFILOS, PROLIFERAÇÃO CELULAR, MYCOBACTERIUM BOVIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOMFIM, Caio César Barbosa et al. Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria. Journal of Infectious Diseases, v. 223, n. 3, p. 494–507, 2021Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiaa708. Acesso em: 18 nov. 2024.
APA
Bomfim, C. C. B., Amaral, E. P., Carvalho, I. S., Santos, G. A., Salles, É. M. de, Hastreiter, A. A., et al. (2021). Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria. Journal of Infectious Diseases, 223( 3), 494–507. doi:10.1093/infdis/jiaa708
NLM
Bomfim CCB, Amaral EP, Carvalho IS, Santos GA, Salles ÉM de, Hastreiter AA, Nascimento RS do, Almeida FM, Simão TLBV, Rezende AL, Hirata MH, Fock RA, Alvarez JM, Lasunskaia EB, Lima MRD'I. Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria [Internet]. Journal of Infectious Diseases. 2021 ; 223( 3): 494–507.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/infdis/jiaa708
Vancouver
Bomfim CCB, Amaral EP, Carvalho IS, Santos GA, Salles ÉM de, Hastreiter AA, Nascimento RS do, Almeida FM, Simão TLBV, Rezende AL, Hirata MH, Fock RA, Alvarez JM, Lasunskaia EB, Lima MRD'I. Harmful effects of granulocytic myeloid-derived suppressor cells on tuberculosis caused by hypervirulent mycobacteria [Internet]. Journal of Infectious Diseases. 2021 ; 223( 3): 494–507.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1093/infdis/jiaa708
Artigo de periodico
Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study (2020)
Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Genvigir, Fabiana Dalla Vecchia ; Bonezi, Vivian; Hirata, Thiago Dominguez Crespo ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Epigenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renata Caroline Costa de et al. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, v. 12, n. 22, p. 2019-2034, 2020Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0160. Acesso em: 18 nov. 2024.
APA
Freitas, R. C. C. de, Bortolin, R. H., Genvigir, F. D. V., Bonezi, V., Hirata, T. D. C., Felipe, C. R., et al. (2020). Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study. Epigenomics, 12( 22), 2019-2034. doi:10.2217/epi-2020-0160
NLM
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0160
Vancouver
Freitas RCC de, Bortolin RH, Genvigir FDV, Bonezi V, Hirata TDC, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study [Internet]. Epigenomics. 2020 ; 12( 22): 2019-2034.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/epi-2020-0160
Artigo de periodico
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy (2020)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Doi, Sonia de Quateli; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Herrero, María José; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, v. 21, n. 1, p. 7-21, 2020Tradução . . Disponível em: https://doi.org/10.2217/pgs-2019-0120. Acesso em: 18 nov. 2024.
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. de Q., et al. (2020). CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy. Pharmacogenomics, 21( 1), 7-21. doi:10.2217/pgs-2019-0120
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Doi S de Q, Cerda A, Hirata MH, Herrero MJ, Hirata RDC. CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy [Internet]. Pharmacogenomics. 2020 ; 21( 1): 7-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/pgs-2019-0120
Artigo de periodico
High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection (2020)
Alves, Matheus Silva; Cariolano, Marilha da Silva; Ferreira, Hivylla Lorrana dos Santos; Silva, Elen Sousa de Abreu; Felipe, Karen Karollynny Pereira; Monteiro, Silvio Gomes; Sousa, Eduardo Martins de; Abreu, Afonso Gomes; Campbell, Lee Ann; Rosenfeld, Michael E; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Bastos, Gisele Medeiros ; Silva, Ilana Cristina de Paula Abreu; Lima Neto, Lidio Gonçalves
Source: Brazilian Journal of Microbiology. Unidade: FCF
Subjects: INFECÇÕES RESPIRATÓRIAS, CHLAMYDIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Matheus Silva et al. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection. Brazilian Journal of Microbiology, v. 51, p. 629–636, 2020Tradução . . Disponível em: https://doi.org/10.1007/s42770-020-00229-w. Acesso em: 18 nov. 2024.
APA
Alves, M. S., Cariolano, M. da S., Ferreira, H. L. dos S., Silva, E. S. de A., Felipe, K. K. P., Monteiro, S. G., et al. (2020). High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection. Brazilian Journal of Microbiology, 51, 629–636. doi:10.1007/s42770-020-00229-w
NLM
Alves MS, Cariolano M da S, Ferreira HL dos S, Silva ES de A, Felipe KKP, Monteiro SG, Sousa EM de, Abreu AG, Campbell LA, Rosenfeld ME, Hirata MH, Hirata RDC, Bastos GM, Silva IC de PA, Lima Neto LG. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection [Internet]. Brazilian Journal of Microbiology. 2020 ; 51 629–636.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s42770-020-00229-w
Vancouver
Alves MS, Cariolano M da S, Ferreira HL dos S, Silva ES de A, Felipe KKP, Monteiro SG, Sousa EM de, Abreu AG, Campbell LA, Rosenfeld ME, Hirata MH, Hirata RDC, Bastos GM, Silva IC de PA, Lima Neto LG. High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection [Internet]. Brazilian Journal of Microbiology. 2020 ; 51 629–636.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s42770-020-00229-w
Artigo de periodico
Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy (2020)
Bonezi, Vivian; Genvigir, Fabiana Dalla Vecchia; Salgado, Patricia de Cássia; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro ; Doi, Sonia Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Annals of Translational Medicine. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONEZI, Vivian et al. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. Annals of Translational Medicine, v. 8, n. 17 p. 1-14 art. 1051, 2020Tradução . . Disponível em: https://doi.org/10.21037/atm-20-1757. Acesso em: 18 nov. 2024.
APA
Bonezi, V., Genvigir, F. D. V., Salgado, P. de C., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., et al. (2020). Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy. Annals of Translational Medicine, 8( 17 p. 1-14 art. 1051). doi:10.21037/atm-20-1757
NLM
Bonezi V, Genvigir FDV, Salgado P de C, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy [Internet]. Annals of Translational Medicine. 2020 ; 8( 17 p. 1-14 art. 1051):[citado 2024 nov. 18 ] Available from: https://doi.org/10.21037/atm-20-1757
Vancouver
Bonezi V, Genvigir FDV, Salgado P de C, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Doi SQ, Hirata MH, Hirata RDC. Differential expression of genes related to calcineurin and mTOR signaling and regulatory miRNAs in peripheral blood from kidney recipients under tacrolimus-based therapy [Internet]. Annals of Translational Medicine. 2020 ; 8( 17 p. 1-14 art. 1051):[citado 2024 nov. 18 ] Available from: https://doi.org/10.21037/atm-20-1757
Artigo de periodico
Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients (2017)
Salgado, Patricia de Cássia; Genvigir, Fabiana Dalla Vecchia; Felipe, Claudia R; Silva Junior, Helio Tedesco; Pestana, Jose Osmar Medina; Doi, Sonia Q; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics and Personalized Medicine. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, POLIMORFISMO, BRASILEIROS, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALGADO, Patricia de Cássia et al. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients. Pharmacogenomics and Personalized Medicine, v. 10, p. 101-106, 2017Tradução . . Disponível em: https://doi.org/10.2147/pgpm.s131390. Acesso em: 18 nov. 2024.
APA
Salgado, P. de C., Genvigir, F. D. V., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Doi, S. Q., et al. (2017). Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients. Pharmacogenomics and Personalized Medicine, 10, 101-106. doi:10.2147/pgpm.s131390
NLM
Salgado P de C, Genvigir FDV, Felipe CR, Silva Junior HT, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients [Internet]. Pharmacogenomics and Personalized Medicine. 2017 ; 10 101-106.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2147/pgpm.s131390
Vancouver
Salgado P de C, Genvigir FDV, Felipe CR, Silva Junior HT, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients [Internet]. Pharmacogenomics and Personalized Medicine. 2017 ; 10 101-106.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2147/pgpm.s131390
Artigo de periodico
Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats (2017)
Ferreira, Elaine C. S; Bortolin, Raul H; Freire-Neto, Francisco Paulo; Souza, Karla S. C; Bezerra, João F; Ururahy, Marcela Abbott Galvão; Ramos, Ana M. O; Himelfarb, Silvia Tchernin; Abreu, Bento J; Didone, Thiago Vinicios Nadaleto; Pedrosa, Lucia F. C; Medeiros, Aldo C; Doi, Sonia Q; Brandão Neto, José; Hirata, Rosario Dominguez Crespo ; Rezende, Luciana A; Almeida, Maria G; Hirata, Mario Hiroyuki ; Rezende, Adriana A
Source: Nutrition Research. Unidade: FCF
Subjects: ZINCO, ESTRÓGENOS, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Elaine C. S et al. Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats. Nutrition Research, v. 40, p. 48-56, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.nutres.2017.03.004. Acesso em: 18 nov. 2024.
APA
Ferreira, E. C. S., Bortolin, R. H., Freire-Neto, F. P., Souza, K. S. C., Bezerra, J. F., Ururahy, M. A. G., et al. (2017). Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats. Nutrition Research, 40, 48-56. doi:10.1016/j.nutres.2017.03.004
NLM
Ferreira ECS, Bortolin RH, Freire-Neto FP, Souza KSC, Bezerra JF, Ururahy MAG, Ramos AMO, Himelfarb ST, Abreu BJ, Didone TVN, Pedrosa LFC, Medeiros AC, Doi SQ, Brandão Neto J, Hirata RDC, Rezende LA, Almeida MG, Hirata MH, Rezende AA. Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats [Internet]. Nutrition Research. 2017 ; 40 48-56.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.nutres.2017.03.004
Vancouver
Ferreira ECS, Bortolin RH, Freire-Neto FP, Souza KSC, Bezerra JF, Ururahy MAG, Ramos AMO, Himelfarb ST, Abreu BJ, Didone TVN, Pedrosa LFC, Medeiros AC, Doi SQ, Brandão Neto J, Hirata RDC, Rezende LA, Almeida MG, Hirata MH, Rezende AA. Zinc supplementation reduces RANKL/OPG ratio and prevents bone architecture alterations in ovariectomized and type 1 diabetic rats [Internet]. Nutrition Research. 2017 ; 40 48-56.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.nutres.2017.03.004
Artigo de periodico
Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients (2017)
Genvigir, Fabiana D. V; Nishikawa, Alvaro Mitsunori; Felipe, Claudia R; Silva Junior, Helio Tedesco; Oliveira, Nagilla; Salazar, Antony B. C; Pestana, José O. Medina; Doi, Sonia Q; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacotherapy. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana D. V et al. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients. Pharmacotherapy, v. 37, n. 5, p. 535-545, 2017Tradução . . Disponível em: https://doi.org/10.1002/phar.1928. Acesso em: 18 nov. 2024.
APA
Genvigir, F. D. V., Nishikawa, A. M., Felipe, C. R., Silva Junior, H. T., Oliveira, N., Salazar, A. B. C., et al. (2017). Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients. Pharmacotherapy, 37( 5), 535-545. doi:10.1002/phar.1928
NLM
Genvigir FDV, Nishikawa AM, Felipe CR, Silva Junior HT, Oliveira N, Salazar ABC, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients [Internet]. Pharmacotherapy. 2017 ; 37( 5): 535-545.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/phar.1928
Vancouver
Genvigir FDV, Nishikawa AM, Felipe CR, Silva Junior HT, Oliveira N, Salazar ABC, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in Brazilian kidney transplant recipients [Internet]. Pharmacotherapy. 2017 ; 37( 5): 535-545.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1002/phar.1928
Artigo de periodico
Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial (2017)
Kawauchi, Tatiana Satie; Umeda, Iracema Ioco Kikuchi; Braga, Lays Magalhães; Mansur, Antonio de Padua; Rossi Neto, João Manoel; Sousa, Amanda Guerra de Moraes Rego; Hirata, Mario Hiroyuki ; Cahalin, Lawrence P; Nakagawa, Naomi Kondo
Source: Clinical Research in Cardiology. Unidades: FM, FCF
Subjects: MÚSCULOS DO SISTEMA RESPIRATÓRIO, INSUFICIÊNCIA CARDÍACA, REABILITAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWAUCHI, Tatiana Satie et al. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial. Clinical Research in Cardiology, v. 106, n. 9, p. 676-685, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00392-017-1089-y. Acesso em: 18 nov. 2024.
APA
Kawauchi, T. S., Umeda, I. I. K., Braga, L. M., Mansur, A. de P., Rossi Neto, J. M., Sousa, A. G. de M. R., et al. (2017). Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial. Clinical Research in Cardiology, 106( 9), 676-685. doi:10.1007/s00392-017-1089-y
NLM
Kawauchi TS, Umeda IIK, Braga LM, Mansur A de P, Rossi Neto JM, Sousa AG de MR, Hirata MH, Cahalin L P, Nakagawa NK. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial [Internet]. Clinical Research in Cardiology. 2017 ; 106( 9): 676-685.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00392-017-1089-y
Vancouver
Kawauchi TS, Umeda IIK, Braga LM, Mansur A de P, Rossi Neto JM, Sousa AG de MR, Hirata MH, Cahalin L P, Nakagawa NK. Is there any benefit using low-intensity inspiratory and peripheral muscle training in heart failure? A randomized clinical trial [Internet]. Clinical Research in Cardiology. 2017 ; 106( 9): 676-685.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00392-017-1089-y
Trabalho de evento-resumo periodico
Influência de polimorfismos nos genes ABCC2 e ABCG2 em parâmetros farmacocinéticos e na segurança do tratamento com tacrolimo e micofenolato de sódio em transplantados renais (2016)
Genvigir, Fabiana Dalla Vecchia; Nishikawa, Alvaro Mitsunori; Salgado, Patricia de Cássia; Salazar, A. B. C; Bonezi, Vivian; Felipe, C R; Silva Jr, H. T; Pestana, J O M; Doi, S Q; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Revista Brasileira de Análises Clínicas (RBAC). Conference titles: Congresso Brasileiro de Análises Clínicas. Unidade: FCF
Subjects: POLIMORFISMO, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. Influência de polimorfismos nos genes ABCC2 e ABCG2 em parâmetros farmacocinéticos e na segurança do tratamento com tacrolimo e micofenolato de sódio em transplantados renais. Revista Brasileira de Análises Clínicas (RBAC). Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2016
APA
Genvigir, F. D. V., Nishikawa, A. M., Salgado, P. de C., Salazar, A. B. C., Bonezi, V., Felipe, C. R., et al. (2016). Influência de polimorfismos nos genes ABCC2 e ABCG2 em parâmetros farmacocinéticos e na segurança do tratamento com tacrolimo e micofenolato de sódio em transplantados renais. Revista Brasileira de Análises Clínicas (RBAC). Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Genvigir FDV, Nishikawa AM, Salgado P de C, Salazar ABC, Bonezi V, Felipe CR, Silva Jr HT, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Influência de polimorfismos nos genes ABCC2 e ABCG2 em parâmetros farmacocinéticos e na segurança do tratamento com tacrolimo e micofenolato de sódio em transplantados renais. Revista Brasileira de Análises Clínicas (RBAC). 2016 ; 48( 2): 45 res. P-118.[citado 2024 nov. 18 ]
Vancouver
Genvigir FDV, Nishikawa AM, Salgado P de C, Salazar ABC, Bonezi V, Felipe CR, Silva Jr HT, Pestana JOM, Doi SQ, Hirata MH, Hirata RDC. Influência de polimorfismos nos genes ABCC2 e ABCG2 em parâmetros farmacocinéticos e na segurança do tratamento com tacrolimo e micofenolato de sódio em transplantados renais. Revista Brasileira de Análises Clínicas (RBAC). 2016 ; 48( 2): 45 res. P-118.[citado 2024 nov. 18 ]
Artigo de periodico
Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients (2016)
Genvigir, F. D. V.; Salgado, P. C.; Felipe, C. R.; Luo, E. Y. F.; Alves, C.; Cerda, A.; Silva Junior, H. T.; Pestana, J. O. M.; Oliveira, N.; Rodrigues, Alice Cristina ; Doi, S. Q.; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenetics and Genomics. Unidades: ICB, FCF
Subjects: POLIMORFISMO, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, F. D. V. et al. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients. Pharmacogenetics and Genomics, v. 26, n. 10, p. 462-472, 2016Tradução . . Disponível em: https://doi.org/10.1097/FPC.0000000000000237. Acesso em: 18 nov. 2024.
APA
Genvigir, F. D. V., Salgado, P. C., Felipe, C. R., Luo, E. Y. F., Alves, C., Cerda, A., et al. (2016). Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients. Pharmacogenetics and Genomics, 26( 10), 462-472. doi:10.1097/FPC.0000000000000237
NLM
Genvigir FDV, Salgado PC, Felipe CR, Luo EYF, Alves C, Cerda A, Silva Junior HT, Pestana JOM, Oliveira N, Rodrigues AC, Doi SQ, Hirata MH, Hirata RDC. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients [Internet]. Pharmacogenetics and Genomics. 2016 ; 26( 10): 462-472.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/FPC.0000000000000237
Vancouver
Genvigir FDV, Salgado PC, Felipe CR, Luo EYF, Alves C, Cerda A, Silva Junior HT, Pestana JOM, Oliveira N, Rodrigues AC, Doi SQ, Hirata MH, Hirata RDC. Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients [Internet]. Pharmacogenetics and Genomics. 2016 ; 26( 10): 462-472.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1097/FPC.0000000000000237

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Non normalized affiliation